Stress as a risk factor in the pathogenesis of rheumatoid arthritis

被引:82
作者
Cutolo, Maurizio
Straub, Rainer H.
机构
[1] Univ Genoa, Dept Internal Med, Res Lab, IT-16132 Genoa, Italy
[2] Univ Genoa, Dept Internal Med, Acad Clin Unit Rheumatol, IT-16132 Genoa, Italy
[3] Univ Hosp, Dept Internal Med 1, Div Rheumatol, Lab Expt Rheumatol & Neuroendocrino Immunol, Regensburg, Germany
关键词
stress; stress response system; autoimmune rheumatic diseases; cortisol; norepinephrine; rheumatoid arthritis;
D O I
10.1159/000104855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stress is now recognized as an important risk factor in the pathogenesis of autoimmune rheumatic diseases (i.e. rheumatoid arthritis) by considering that the activation of the stress response system influences the close relationships existing between the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system and the immune system. The stress response results in the release of neurotransmitters (norepinephrine), hormones ( cortisol) and immune cells which serve to send an efferent message from the brain to the periphery. Major life events lead to an intense release of stress mediators (large time integral of released neurotransmitters and hormones), whereas in minor life events, only short-lived surges of neurotransmitters and hormones are expected. Therefore, it is suggested that neurotransmitters such as norepinephrine or stress hormones such as cortisol might have different effects on immune/inflammatory responses at high and low concentrations present during short or extended periods of time, respectively. Long-lasting ( chronic) stress may lead to proinflammatory effects because no adequate long-term responses of stress axes (antiinflammatory) are to be expected. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 42 条
  • [1] BAERWALD C, 1992, J RHEUMATOL, V19, P204
  • [2] BARBER AE, 1993, J IMMUNOL, V150, P1999
  • [3] Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids
    BrougHolub, E
    Kraal, G
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02) : 332 - 336
  • [4] Glucocorticoids in the treatment of rheumatic diseases - An update on the mechanisms of action
    Buttgereit, F
    Straub, RH
    Wehling, M
    Burmester, GR
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3408 - 3417
  • [5] SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION
    CHROUSOS, GP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) : 1351 - 1362
  • [6] COOPER DA, 1979, CLIN EXP IMMUNOL, V37, P145
  • [7] Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis
    Crofford, LJ
    Kalogeras, KT
    Mastorakos, G
    Magiakou, MA
    Wells, J
    Kanik, KS
    Gold, PW
    Chrousos, GP
    Wilder, RL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) : 1279 - 1283
  • [8] Cutolo M, 1999, CLIN EXP RHEUMATOL, V17, P515
  • [9] Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms
    Cutolo, M
    Villaggio, B
    Otsa, K
    Aakre, O
    Sulli, A
    Seriolo, B
    [J]. AUTOIMMUNITY REVIEWS, 2005, 4 (08) : 497 - 502
  • [10] Cutolo M, 1999, J RHEUMATOL, V26, P282